vs
Side-by-side financial comparison of KeyCorp (KEY) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
KeyCorp is the larger business by last-quarter revenue ($2.0B vs $1.1B, roughly 1.8× PERRIGO Co plc). KeyCorp runs the higher net margin — 25.4% vs -127.8%, a 153.2% gap on every dollar of revenue. On growth, KeyCorp posted the faster year-over-year revenue change (131.8% vs -2.5%). KeyCorp produced more free cash flow last quarter ($2.1B vs $148.6M). Over the past eight quarters, KeyCorp's revenue compounded faster (14.4% CAGR vs 1.3%).
Key is a Japanese visual novel studio known for making dramatic and plot-oriented titles. It was formed on July 21, 1998, as a brand under the publisher Visual Arts, and is located in Kita, Osaka.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
KEY vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.0B | $1.1B |
| Net Profit | $510.0M | $-1.4B |
| Gross Margin | — | 32.6% |
| Operating Margin | 32.3% | -116.0% |
| Net Margin | 25.4% | -127.8% |
| Revenue YoY | 131.8% | -2.5% |
| Net Profit YoY | 309.0% | -3093.9% |
| EPS (diluted) | $0.43 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.0B | $1.1B | ||
| Q3 25 | $1.9B | $1.0B | ||
| Q2 25 | $1.8B | $1.1B | ||
| Q1 25 | $1.8B | $1.0B | ||
| Q4 24 | $865.0M | $1.1B | ||
| Q3 24 | $695.0M | $1.1B | ||
| Q2 24 | $1.5B | $1.1B | ||
| Q1 24 | $1.5B | $1.1B |
| Q4 25 | $510.0M | $-1.4B | ||
| Q3 25 | $489.0M | $7.5M | ||
| Q2 25 | $425.0M | $-8.4M | ||
| Q1 25 | $405.0M | $-6.4M | ||
| Q4 24 | $-244.0M | $-44.4M | ||
| Q3 24 | $-410.0M | $-21.0M | ||
| Q2 24 | $274.0M | $-108.4M | ||
| Q1 24 | $219.0M | $2.0M |
| Q4 25 | — | 32.6% | ||
| Q3 25 | — | 36.1% | ||
| Q2 25 | — | 34.4% | ||
| Q1 25 | — | 37.6% | ||
| Q4 24 | — | 33.9% | ||
| Q3 24 | — | 37.2% | ||
| Q2 24 | — | 37.0% | ||
| Q1 24 | — | 33.1% |
| Q4 25 | 32.3% | -116.0% | ||
| Q3 25 | 31.8% | 7.0% | ||
| Q2 25 | 29.3% | 4.3% | ||
| Q1 25 | 29.0% | 4.5% | ||
| Q4 24 | -92.6% | 10.0% | ||
| Q3 24 | -72.8% | 7.4% | ||
| Q2 24 | 22.0% | -2.5% | ||
| Q1 24 | 18.1% | -5.1% |
| Q4 25 | 25.4% | -127.8% | ||
| Q3 25 | 25.8% | 0.7% | ||
| Q2 25 | 23.1% | -0.8% | ||
| Q1 25 | 22.8% | -0.6% | ||
| Q4 24 | -54.7% | -3.9% | ||
| Q3 24 | -59.0% | -1.9% | ||
| Q2 24 | 18.0% | -10.2% | ||
| Q1 24 | 14.3% | 0.2% |
| Q4 25 | $0.43 | $-10.23 | ||
| Q3 25 | $0.41 | $0.05 | ||
| Q2 25 | $0.35 | $-0.06 | ||
| Q1 25 | $0.33 | $-0.05 | ||
| Q4 24 | $-0.30 | $-0.32 | ||
| Q3 24 | $-0.47 | $-0.15 | ||
| Q2 24 | $0.25 | $-0.79 | ||
| Q1 24 | $0.20 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $10.2B | — |
| Total DebtLower is stronger | $9.9B | — |
| Stockholders' EquityBook value | $20.4B | $2.9B |
| Total Assets | $184.4B | $8.5B |
| Debt / EquityLower = less leverage | 0.49× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.2B | — | ||
| Q3 25 | $13.3B | $432.1M | ||
| Q2 25 | $11.6B | $454.2M | ||
| Q1 25 | $15.3B | $409.9M | ||
| Q4 24 | $17.5B | $558.8M | ||
| Q3 24 | $22.8B | $1.5B | ||
| Q2 24 | $15.5B | $542.8M | ||
| Q1 24 | $13.2B | $658.5M |
| Q4 25 | $9.9B | — | ||
| Q3 25 | $10.9B | — | ||
| Q2 25 | $12.1B | — | ||
| Q1 25 | $12.4B | — | ||
| Q4 24 | $12.1B | — | ||
| Q3 24 | $15.7B | — | ||
| Q2 24 | $16.9B | — | ||
| Q1 24 | $20.8B | — |
| Q4 25 | $20.4B | $2.9B | ||
| Q3 25 | $20.1B | $4.4B | ||
| Q2 25 | $19.5B | $4.5B | ||
| Q1 25 | $19.0B | $4.4B | ||
| Q4 24 | $18.2B | $4.3B | ||
| Q3 24 | $16.9B | $4.6B | ||
| Q2 24 | $14.8B | $4.5B | ||
| Q1 24 | $14.5B | $4.7B |
| Q4 25 | $184.4B | $8.5B | ||
| Q3 25 | $187.4B | $10.1B | ||
| Q2 25 | $185.5B | $10.1B | ||
| Q1 25 | $188.7B | $9.8B | ||
| Q4 24 | $187.2B | $9.6B | ||
| Q3 24 | $189.8B | $11.2B | ||
| Q2 24 | $187.4B | $10.4B | ||
| Q1 24 | $187.5B | $10.6B |
| Q4 25 | 0.49× | — | ||
| Q3 25 | 0.54× | — | ||
| Q2 25 | 0.62× | — | ||
| Q1 25 | 0.65× | — | ||
| Q4 24 | 0.67× | — | ||
| Q3 24 | 0.93× | — | ||
| Q2 24 | 1.14× | — | ||
| Q1 24 | 1.43× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.2B | $175.4M |
| Free Cash FlowOCF − Capex | $2.1B | $148.6M |
| FCF MarginFCF / Revenue | 104.8% | 13.4% |
| Capex IntensityCapex / Revenue | 5.3% | 2.4% |
| Cash ConversionOCF / Net Profit | 4.33× | — |
| TTM Free Cash FlowTrailing 4 quarters | $3.5B | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.2B | $175.4M | ||
| Q3 25 | $396.0M | $51.7M | ||
| Q2 25 | $1.2B | $75.9M | ||
| Q1 25 | $-140.0M | $-64.5M | ||
| Q4 24 | $664.0M | $312.6M | ||
| Q3 24 | $-1.2B | $42.2M | ||
| Q2 24 | $-217.0M | $9.5M | ||
| Q1 24 | $359.0M | $-1.4M |
| Q4 25 | $2.1B | $148.6M | ||
| Q3 25 | $367.0M | $29.8M | ||
| Q2 25 | $1.2B | $56.7M | ||
| Q1 25 | $-150.0M | $-90.0M | ||
| Q4 24 | $599.0M | $274.9M | ||
| Q3 24 | $-1.2B | $15.1M | ||
| Q2 24 | $-230.0M | $-18.9M | ||
| Q1 24 | $347.0M | $-26.5M |
| Q4 25 | 104.8% | 13.4% | ||
| Q3 25 | 19.4% | 2.9% | ||
| Q2 25 | 65.8% | 5.4% | ||
| Q1 25 | -8.5% | -8.6% | ||
| Q4 24 | 69.2% | 24.2% | ||
| Q3 24 | -175.8% | 1.4% | ||
| Q2 24 | -15.1% | -1.8% | ||
| Q1 24 | 22.6% | -2.4% |
| Q4 25 | 5.3% | 2.4% | ||
| Q3 25 | 1.5% | 2.1% | ||
| Q2 25 | 1.3% | 1.8% | ||
| Q1 25 | 0.6% | 2.4% | ||
| Q4 24 | 7.5% | 3.3% | ||
| Q3 24 | 2.4% | 2.5% | ||
| Q2 24 | 0.9% | 2.7% | ||
| Q1 24 | 0.8% | 2.3% |
| Q4 25 | 4.33× | — | ||
| Q3 25 | 0.81× | 6.89× | ||
| Q2 25 | 2.90× | — | ||
| Q1 25 | -0.35× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.79× | — | ||
| Q1 24 | 1.64× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KEY
Segment breakdown not available.
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
